Preclinical and clinical evaluation of the RAF/MEK clamp avutometinib (VS-6766) in combination with the mTOR inhibitor everolimus for the treatment of KRAS mutated non-small cell lung cancer

被引：0
|
作者：
Rodney, Simon
Stewart, Adam R.
Perez, Victoria Sanchez
Morton, Cienne
Pickard, Lisa A.
Shakouri, Taleen
Prout, Toby
Parmar, Mona
Turner, Alison J.
Coma, Silvia
Pachter, Jonathan
Finneran, Laura
Hall, Emma
Spicer, James
Minchom, Anna
Banerji, Udai
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3461
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3461
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Sotorasib treatment in KRAS G12C-mutated non-small cell lung cancer: Experience in the Tours university hospital
    Bessy, C.
    Blin, T.
    Pichon, E.
    Marchand-Adam, S.
    Carmier, D.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (01) : 17 - 23
  • [42] Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer
    Zhong, Lei
    Yang, Jiao
    Cao, Zhixing
    Chen, Xin
    Hu, Yiguo
    Li, Linli
    Yang, Shengyong
    ONCOTARGET, 2017, 8 (08) : 12843 - 12854
  • [43] Preclinical evidence for synergistic effects of autophagy inhibitor and alpelisib in PI3KCA mutated non-small cell lung cancer: Implications for future clinical trials
    Shim, Byoung Yong
    Lee, Sang-Bin
    Kim, Hyunho
    Park, Hyung Soon
    An, Ho Jung
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Triple combination therapy comprising osimertinib, an AXL inhibitor, and an FGFR inhibitor improves the efficacy of EGFR-mutated non-small cell lung cancer
    Nakamura, Ryota
    Yamada, Tadaaki
    Tokuda, Shinsaku
    Morimoto, Kenji
    Katayama, Yuki
    Matsui, Yohei
    Hirai, Soichi
    Ishida, Masaki
    Kawachi, Hayato
    Sawada, Ryo
    Tachibana, Yusuke
    Osoegawa, Atsushi
    Horinaka, Mano
    Sakai, Toshiyuki
    Yasuhiro, Tomoko
    Kozaki, Ryohei
    Yano, Seiji
    Takayama, Koichi
    CANCER LETTERS, 2024, 598
  • [45] MEK inhibitor combined with RTK inhibitor (trametinib plus anlotinib) in non-G12C KRAS-mutant non-small cell lung cancer: A new strategy
    Han, Baohui
    Lu, Jun
    Zhong, Hua
    Chu, Tianqing
    Zhang, Wei
    Hu, Minjuan
    Shi, Chunlei
    Xiong, Liwen
    Gu, Aiqin
    Wang, Huimin
    Lou, Yuqing
    Zhang, Yanwei
    Zhong, Runbo
    Gao, Zhiqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] MEK Inhibitor Combined with RTK Inhibitor (Trametinib Plus Anlotinib) In Non-g12c KRAS-Mutant Non-Small Cell Lung Cancer: A New Strategy
    Han, B.
    Lu, J.
    Zhong, H.
    Chu, T.
    Zhang, W.
    Hu, M.
    Shi, C.
    Xiong, L.
    Gu, A.
    Wang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S351 - S351
  • [47] Clinical characteristics and treatment outcomes of 65 patients with BRAF-mutated non-small cell lung cancer (NSCLC).
    Mu, Yuxin
    Yang, Ke
    Hao, Xuezhi
    Wang, Yan
    Wang, Lin
    Liu, Yutao
    Lin, Lin
    Li, Junling
    Xing, Puyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib
    Park, Kang-Seo
    Oh, Bora
    Lee, Mi-Hee
    Nam, Ky-Youb
    Jin, Hae Ran
    Yang, Hannah
    Choi, Junyoung
    Kim, Sang -We
    Lee, Dae Ho
    CANCER LETTERS, 2016, 372 (01) : 75 - 81
  • [49] Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review
    Santarpia, Mariacarmela
    Ciappina, Giuliana
    Spagnolo, Calogera Claudia
    Squeri, Andrea
    Passalacqua, Maria Ilenia
    Aguilar, Andres
    Gonzalez-Cao, Maria
    Giovannetti, Elisa
    Silvestris, Nicola
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (02) : 346 - 368
  • [50] Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer
    Altan, Mehmet
    Tu, Janet
    Milton, Denai R.
    Yilmaz, Bulent
    Tian, Yanyan
    Fossella, Frank V.
    Mott, Frank E.
    Blumenschein, George R.
    Stephen, Bettzy
    Karp, Daniel D.
    Meric-Bernstam, Funda
    Heymach, John V.
    Naing, Aung
    CANCER, 2023, 129 (17) : 2685 - 2693
12345